News - POCTRN

First ever 30-minute, CLIA-waived, molecular PCR Test for CT/NG now available for OBGYN, physician offices and retail settings holding certificates of waiver

Emergence of SARS-CoV-2 Variants and Impact on IVD Testing

WhenToTest.org

The COVD19 Testing Impact Calculator

Future potential of Rapid Acceleration of Diagnostics (RADx Tech) in molecular diagnostics

Now Accepting Applications: POCTRN Solicitation 2021

RADx Tech Webinar Series - A Path to In-Person Instruction: On-Campus Pooling in a Pod Testing for COVID-19

Register by January 25

RADx Tech Webinar Series: Innovation During the Pandemic: Personal Protection Testing Booths for COVID-19

Watch the Recording

NIH-funded COVID-19 home test is first to receive over-the-counter authorization from FDA

Ellume USA’s rapid at-home test was developed through the NIH RADx Initiative.

Rebuilding Trust in Air Travel: Using Alternative Data to Help Airports Respond to COVID-19

Register by Feb. 8

University Lab Partners Selected by CIMIT to Partner in their Project to Support the NIH RADx Initiative

NIH RADx Initiative Advances Six New COVID-19 Testing Technologies

RADx Tech Webinar Series: Delivering New COVID-19 Technologies to Close the Testing Gap in the US Market

Register for this exciting three-part series

Overcoming Challenges With the Adoption of Point-of-Care Testing

From Technology Push and Clinical Needs to Value Propositions

NIH Continues to Boost National COVID-19 Testing Capacity

New laboratory and point-of-care tests to enable access and rapid results

The Forsyth Institute Serving as a Critical Resource for COVID-19 Saliva Diagnostic Test Development

Webinar: Covid-19 Testing - Moving from Clinical Settings into the Community

Webinar: Insights from User Discussions on COVID-19 Testing in Non-Traditional Settings

Webinar: Returning to Normal Activities - A Modeling Tool to Assist in Planning

NIH delivering new COVID-19 testing technologies to meet U.S. demand

Range of new technologies will meet testing needs in diverse settings

NIH LIVE QA Session

RADX Delivering new COVID-19 Testing Tech to Meet US Demand

Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States — The NIH RADx Initiative

The capital will be used to scale up testing capacity of PathogenDx's Microarray Assay for COVID-19 testing nationally

Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States — The NIH RADx Initiative

3M and MIT Researchers Developing a Rapid Diagnostic Test for COVID-19

The goal is a new, highly accurate, mass-produced low-cost diagnostic device that delivers results in minutes.

RADx Tech COVID19 Webinar Series: As the Coronavirus Pandemic Unfolds...

The Challenges of COVID-19 / SARS-CoV-2 Diagnostics

RADx Tech COVID19 Webinar Series: Regulatory Affairs on the RADx Frontlines

Perspective from a Point-of-Care Technology Research Center

RADx Tech COVID19 Webinar Series: As the Coronavirus Pandemic Unfolds...

User Centered Design for the Rapid Acceleration of Diagnostics for COVID19

RADx-UP Funding Opportunities and Webinar

Francis Collins Testifies Before Congress, May 7, 2020

Shark Tank: New Tests for COVID-19

Important COVID-19 Survey

Please complete the survey below as soon as possible - within the next few days if possible.

NIH Announces $1 Million Prize Competition to Target Global Disease Diagnostics

Bill & Melinda Gates Foundation to offer supplementary support for designs that can be developed into products on a rapid timeframe

GLUE Lecture: Establishing a Viable Business Model for your Medical Device

POCTRN CRAASH 2020

Check out the scenes from the kick-off session.

Now Accepting Applications: POCTRN Solicitation 2020

Four New Funding Opportunities

Use of a Rapid Diagnostic for Chlamydia trachomatis and Neisseria gonorrhoeae for Women in the Emergency Department Can Improve Clinical Management: Report of a Randomized Clinical Trial

News - POCTRN

アセットパブリッシャー